Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries

Aripov T. Wikler D. Asadov D. Tulekov Z. Murzabekova T. Munir K.M.
December 2022 BioMed Central Ltd

BMC Medical Ethics
2022 #23 Issue 1

Background: In the pandemic time, many low- and middle-income countries are experiencing restricted access to COVID-19 vaccines. Access to imported vaccines or ways to produce them locally became the principal source of hope for these countries. But developing a strategy for success in obtaining and allocating vaccines was not easy task. The governments in those countries have faced the difficult decision whether to accept or reject offers of vaccine diplomacy, weighing the price and availability of COVID-19 vaccines against the concerns over their efficacy and safety. We aimed to analyze public opinion regarding the governmental strategies to obtain COVID-19 vaccines in three Central Asian countries, focusing particularly on possible ethical issues. Methods: We searched for opinions expressed either in Russian or in the respective national languages. We provided data on the debate within three countries, drawn from social media postings and other sources. The opinion data was not restricted by source and time. This allowed collecting a wide range of possible opinions that could be expressed regarding COVID-19 vaccine supply and human participation in the vaccine trial. We recognized ethical issues and possible questions concerning different ethical frameworks. We also considered scientific data and other information, in the process of reasoning. Results: As a result, public views on their respective government policies on COVID-19 vaccine supply ranged from strongly negative to slightly positive. We extracted the most important issues from public debates, for our analysis. The first issue involved trade-offs between quantity, speed, price, freedom, efficacy, and safety in the vaccines. The second set of issues arose in connection with the request to site a randomized trial in one of the countries (Uzbekistan). After considering additional evidence, we weighed individual and public risks against the benefits to make specific judgements concerning every issue. Conclusions: We believe that our analysis would be a helpful example of solving ethical issues that can arise concerning COVID-19 vaccine supply around the world. The public view can be highly critical, helping to spot such issues. An ignoring this view can lead to major problems, which in turn, can become a serious obstacle for the vaccine coverage and epidemics’ control in the countries and regions.

Bioethics , Central Asia , COVID-19 , Low- and middle-income countries , Vaccine

Text of the article Перейти на текст статьи

Department of Public Health and Healthcare Management, Tashkent Institute of Postgraduate Medical Education, Parkent str. 51, Tashkent, 100007, Uzbekistan
Department of Global Health and Population, Harvard School of Public Health, 677 Huntington Avenue, Boston, 02115, MA, United States
Al-Farabi Kazakh National University, 71 Al-Farabi Avenue, Almaty, 050040, Kazakhstan
Kyrgyz-Netherlands Community of Volunteers Tuberculosis Foundation, Zhantosheva 121/33, Bishkek, Kyrgyzstan
Harvard Medical School, Boston Children’s Hospital, Developmental Medicine Center, 300 Longwood Ave, Boston, 02115, MA, United States

Department of Public Health and Healthcare Management
Department of Global Health and Population
Al-Farabi Kazakh National University
Kyrgyz-Netherlands Community of Volunteers Tuberculosis Foundation
Harvard Medical School

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026